Jiang Xiongjing, Peng Meng, Li Bin, Dong Hui, Che Wuqiang, Zou Yubao, Yang Yuejin, Gao Runlin
a Department of Cardiology , Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China.
Curr Med Res Opin. 2016 Oct;32(sup2):3-7. doi: 10.1080/03007995.2016.1218833.
To evaluate the efficacy of renal artery stent combined with optimal medical therapy as treatment for renal artery stenosis.
A prospective cohort study was conducted. Patients with severe atherosclerotic renal artery stenosis received percutaneous renal artery stent because of poorly controlled hypertension or preservation of renal function. The patients also received optimal medical therapy to achieve the blood pressure, lipid and blood glucose targets.
All patients underwent a 12 month follow-up to observe the effect of the procedure on blood pressure control, number of antihypertensive medications and creatinine level.
Stents were placed in 185 renal arteries of 149 patients. Mean stenosis was 83.1 ± 7.0%. The success rate of renal artery stent was 99.3%. At 12 months, estimated glomerular filtration rate increased significantly compared with baseline (84.1 ± 28.8 vs. 76.5 ± 22.50 ml/min ×1.73 m, p < 0.05). Both office blood pressure and 24 hour blood pressure significantly decreased compared with baseline (from 153/83 mmHg to 134/73 mmHg and from 143/80 mmHg to 124/69 mmHg, respectively; p < 0.05), and less antihypertensive medication was taken compared with baseline (1.5 ± 0.8 vs. 2.2 ± 0.9; p < 0.05).
Renal artery stent combined with optimal medical therapy as a treatment has a beneficial effect on blood pressure control and estimated glomerular filtration rate in selected patients with atherosclerotic renal artery stenosis. Larger studies with a longer follow-up appear necessary to further confirm these intriguing findings.
评估肾动脉支架联合最佳药物治疗对肾动脉狭窄的疗效。
进行了一项前瞻性队列研究。患有严重动脉粥样硬化性肾动脉狭窄的患者因高血压控制不佳或为保护肾功能而接受经皮肾动脉支架置入术。患者还接受了最佳药物治疗以实现血压、血脂和血糖目标。
所有患者均接受了为期12个月的随访,以观察该手术对血压控制、抗高血压药物数量和肌酐水平的影响。
在149例患者的185条肾动脉中置入了支架。平均狭窄率为83.1±7.0%。肾动脉支架置入术的成功率为99.3%。在12个月时,与基线相比,估计肾小球滤过率显著增加(84.1±28.8对76.5±22.50ml/min×1.73m²,p<0.05)。与基线相比,诊室血压和24小时血压均显著降低(分别从153/83mmHg降至134/73mmHg和从143/80mmHg降至124/69mmHg;p<0.05),且与基线相比服用的抗高血压药物更少(1.5±0.8对2.2±0.9;p<0.05)。
对于选定的动脉粥样硬化性肾动脉狭窄患者,肾动脉支架联合最佳药物治疗对血压控制和估计肾小球滤过率有有益影响。似乎有必要进行更大规模、更长随访时间的研究来进一步证实这些有趣的发现。